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Background/introduction
The increased interstitial fluid pressure (IFP) from
vasogenic edema, which results from a leaky blood-
tumor-barrier (BTB), creates a barrier for transvascular
drug delivery, particularly larger molecules that are
unable to diffuse across and must resort to bulk fluid
flow. We have previously used dynamic contrast
enhanced-computed tomography (DCE-CT) to quantita-
tively evaluate the blood-brain-barrier (BBB) response in
normal brain - and have shown that focused ultrasound
(FUS) and microbubble (MB) treatment in a rat brain
demonstrates a 3-4 times transient increase at our opti-
mized parameters. The purpose of this study was to
quantitatively evaluate the BTB response following FUS
and MB treatment in rat glioma, in the context of
improving drug delivery to brain tumors.
Methods
At 10-15 days before treatment, 1 x 106 C6 glioma cells
are surgically implanted using a stereotactic frame into a
region in the right cerebral hemisphere of a Wistar rat.
The rats were broken into 2 groups before treatment: 1)
evaluating the acute response out to 4 h post for tumor
and normal hemispheres (n=3), and 2) recovery at 2 h
post followed by scans at 24 and 72 h post (n=5). The
tumor is transcranially sonicated at previously optimized
parameters that demonstrate transient opening in the
normal BBB without any vascular or tissue damage - 10
ms burst length with 1 Hz repetition frequency for 120s,
with an applied power of 0.5 W, using a 0.563-MHz FUS
system. 2 ul/kg of Definity microbubbles are injected
simultaneously with the start of the sonication. Axial CT
scans as well as the DCE-CT perfusion maps were used
to target the tumor. DCE-CT (80 kVp, 250 mA, axial
slice thickness = 1.25 mm) was performed using a two
phase protocol: 1st phase consisting of continuous 0.5 s
rotations for 30 s, and a 2nd phase of 0.5 s rotations at
14.5 s intervals for 150s. 2.5 ml/kg of iodinated contrast
agent was injected over 5 seconds simultaneous to the
start of each DCE-CT scan. Proprietary CT Perfusion
software was used to compute permeability surface area
product (PS), cerebral blood flow (CBF), cerebral blood
volume (CBV), and mean transit time (MTT) maps using
a standard small molecule contrast agent (Isovue ~ 760
Da) that is able to diffuse across the BTB. The BTB PS
was also evaluated using a much larger contrast agent
(eXia ~ 65,000 Da) that mimics the delivery of agents
such as monoclonal antibodies.
Results and conclusions
Instead of a transient increase in BBB permeability that
is seen in the normal brain, FUS and MB demonstrated
a gradual decrease in BTB permeability in the hours fol-
lowing treatment (p < 0.05). An acute vascular shut-
down, drop in CBF and CBV (p < 0.05), was also
observed immediately following treatment, as previously
reported in other tumor models. The drop in PS per-
sisted at 24 h post (p < 0.05), returning at 72 h post,
whereas the CBF and CBV returned back to baseline
levels by 24 h post. A trend of increasing eXia penetra-
tion suggests that the decrease in BTB PS alleviates the
elevated IFP that results from vasogenic edema and
improves the penetration of larger drugs or molecules
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that are unable to diffuse across the BTB. When plotted
against the MTT, which is the inverse of perfusion pres-
sure, BTB PS (isovue) shows a moderate positive corre-
lation (r2 = 0.71), whereas BTB PS (eXia) shows a weak
negative correlation (r2 = - 0.50). Our findings indicate
that although FUS and MB treatment at our parameters
may not necessarily be useful for increasing the delivery
of small molecule drugs, it may be more useful for
increasing the delivery of larger molecules where the
IFP is a barrier.
Figure 1 Acute blood-tumor-barrier (BTB) and blood-brain-barrier (BBB) permeability surface-area product (PS) time curves following focused
ultrasound (FUS) and microbubble (MB) treatment for the tumor and contralateral hemispheres (n=3)
Figure 2 Blood-tumor-barrier (BTB) permeability surface-area product (PS) maps at baseline,1, 24, and 72 h following focused ultrasound (FUS)
and microbubble (MB) treatment
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Figure 3 Comparison of isovue (~760 Da), and eXia (~65,000 Da) blood-tumor-barrier (BTB) permeability surface-area product (PS) plotted
against the mean-transit-time (MTT) as measured with the standard iodine diffusable iodine contrast (Isovue)
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